Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-09 Tax Withholding |
2025-01-13 4:09 pm |
N/A N/A |
LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO |
7,422 | $3.8 | 92,794 (Direct) |
View |
| 2025-01-10 Tax Withholding |
2025-01-13 4:09 pm |
N/A N/A |
LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO |
456 | $3.73 | 92,794 (Direct) |
View |
| 2025-01-09 Option Award |
2025-01-13 4:09 pm |
2025-01-09 2035-01-09 |
LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO |
38,000 | $0 | 92,794 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-02 5:21 pm |
N/A N/A |
LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO |
15,000 | $2.93 | 62,672 (Direct) |
View |
| 2024-10-01 Tax Withholding |
2024-10-02 5:21 pm |
N/A N/A |
LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO |
6,363 | $2.93 | 62,672 (Direct) |
View |
| 2024-01-10 Tax Withholding |
2024-01-11 4:11 pm |
N/A N/A |
LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO |
512 | $3 | 68,035 (Direct) |
View |
| 2024-01-09 Option Award |
2024-01-11 4:11 pm |
2024-01-09 2034-01-09 |
LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO |
41,000 | $0 | 68,035 (Direct) |
View |
| 2024-01-09 Tax Withholding |
2024-01-11 4:11 pm |
N/A N/A |
LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO |
5,368 | $3.08 | 68,035 (Direct) |
View |
| 2023-09-01 Tax Withholding |
2023-09-05 4:02 pm |
N/A N/A |
LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO |
2,908 | $2.18 | 32,915 (Direct) |
View |
| 2023-01-10 Tax Withholding |
2023-01-11 4:03 pm |
N/A N/A |
LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO |
512 | $3.195 | 44,823 (Direct) |
View |
| 2023-01-09 Tax Withholding |
2023-01-11 4:03 pm |
N/A N/A |
LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO |
2,147 | $3 | 44,823 (Direct) |
View |
| 2023-01-09 Option Award |
2023-01-11 4:03 pm |
2023-01-09 2033-01-09 |
LISATA THERAPEUTICS INC. | LSTA | Buck Kristen K EVP, R&D and CMO |
27,000 | $0 | 44,823 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-02 4:05 pm |
N/A N/A |
CALADRIUS BIOSCIENCES INC. | CLBS | Buck Kristen K EVP, R&D and CMO |
58,000 | $0.5 | 307,244 (Direct) |
View |
| 2022-09-01 Tax Withholding |
2022-09-02 4:05 pm |
N/A N/A |
CALADRIUS BIOSCIENCES INC. | CLBS | Buck Kristen K EVP, R&D and CMO |
69,959 | $0.5 | 307,244 (Direct) |
View |
| 2022-01-10 Option Award |
2022-01-12 4:18 pm |
2022-01-10 2032-01-10 |
CALADRIUS BIOSCIENCES INC. | CLBS | Buck Kristen K EVP, R&D and CMO |
97,000 | $0 | 351,703 (Direct) |
View |
| 2022-01-10 Tax Withholding |
2022-01-12 4:18 pm |
N/A N/A |
CALADRIUS BIOSCIENCES INC. | CLBS | Buck Kristen K EVP, R&D and CMO |
7,694 | $0.917 | 351,703 (Direct) |
View |
| 2021-09-01 Tax Withholding |
2021-09-03 4:04 pm |
N/A N/A |
CALADRIUS BIOSCIENCES INC. | CLBS | Buck Kristen K EVP, R&D and CMO |
50,103 | $1.28 | 1,400,312 (Direct) |
View |
| 2021-09-01 Option Award |
2021-09-03 4:04 pm |
2021-09-01 2031-09-01 |
CALADRIUS BIOSCIENCES INC. | CLBS | Buck Kristen K EVP, R&D and CMO |
1,450,415 | $0 | 1,400,312 (Direct) |
View |